ATE391742T1 - Hydrolytisch abbaubare polyalkylenoxid-polymere - Google Patents

Hydrolytisch abbaubare polyalkylenoxid-polymere

Info

Publication number
ATE391742T1
ATE391742T1 AT03709198T AT03709198T ATE391742T1 AT E391742 T1 ATE391742 T1 AT E391742T1 AT 03709198 T AT03709198 T AT 03709198T AT 03709198 T AT03709198 T AT 03709198T AT E391742 T1 ATE391742 T1 AT E391742T1
Authority
AT
Austria
Prior art keywords
polymer
hydrolytically degradable
hydrolytically
polyalkylene oxide
oxide polymers
Prior art date
Application number
AT03709198T
Other languages
English (en)
Inventor
Michael Bentley
J Harris
Xuan Zhao
William Battle
Xiaoming Shen
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Application granted granted Critical
Publication of ATE391742T1 publication Critical patent/ATE391742T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/18Block or graft polymers
    • C08G64/183Block or graft polymers containing polyether sequences
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33331Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
    • C08G65/33337Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33344Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing carbamate group
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33396Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT03709198T 2002-02-15 2003-02-14 Hydrolytisch abbaubare polyalkylenoxid-polymere ATE391742T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35735002P 2002-02-15 2002-02-15

Publications (1)

Publication Number Publication Date
ATE391742T1 true ATE391742T1 (de) 2008-04-15

Family

ID=27757601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709198T ATE391742T1 (de) 2002-02-15 2003-02-14 Hydrolytisch abbaubare polyalkylenoxid-polymere

Country Status (7)

Country Link
US (2) US20060239961A1 (de)
EP (1) EP1476489B8 (de)
AT (1) ATE391742T1 (de)
AU (1) AU2003213152A1 (de)
DE (1) DE60320224T2 (de)
ES (1) ES2304501T3 (de)
WO (1) WO2003070805A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE391742T1 (de) * 2002-02-15 2008-04-15 Nektar Therapeutics Al Corp Hydrolytisch abbaubare polyalkylenoxid-polymere
WO2004022120A1 (en) * 2002-09-04 2004-03-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions comprising bone marrow cells, demineralized bone matrix and rtg polymers for use in the induction of bone and cartilage formation
WO2006019904A1 (en) 2004-07-14 2006-02-23 University Of Utha Research Foundation Netrin-related compositions and uses
EP1841808B1 (de) * 2004-12-22 2009-01-21 California Institute Of Technology Abbaubare polymere und herstellungsverfahren dafür
WO2006078163A2 (en) * 2005-01-18 2006-07-27 Dolphys Technologies B.V. High molecular weight non-ionic surfactants comprising nitrogen or phosphorus containing groups
EP1861125A2 (de) * 2005-03-23 2007-12-05 Nektar Therapeutics Al, Corporation Konjugate eines hgh-teils und peg-derivate
US7517914B2 (en) 2005-04-04 2009-04-14 Boston Scientificscimed, Inc. Controlled degradation materials for therapeutic agent delivery
US8263109B2 (en) 2005-05-09 2012-09-11 Boston Scientific Scimed, Inc. Injectable bulking compositions
JP5096363B2 (ja) 2005-12-16 2012-12-12 ネクター セラピューティックス Glp−1のポリマ複合体
EP1986695B1 (de) 2006-02-21 2015-06-03 Nektar Therapeutics Segmentierte abbaubare polymere und daraus hergestellte konjugate
SI2054074T1 (sl) * 2006-08-04 2014-12-31 Prolong Pharmaceuticals Llc Modificiran eritropoetin
WO2008033497A1 (en) * 2006-09-14 2008-03-20 The Research Foundation Of State University Of New York Nanostructured smart gel for time release drug delivery
KR100838809B1 (ko) 2007-05-03 2008-06-17 성균관대학교산학협력단 겔강도가 우수한 온도 및 피에치 민감성 블록 공중합체 및이의 제조방법과 이를 이용한 약물전달체
JP5739668B2 (ja) * 2008-02-13 2015-06-24 ハイパーブランチ メディカル テクノロジー, インコーポレイテッド 調節可能な分解速度を有する架橋ポリアルキレンイミンヒドロゲル
WO2009108891A2 (en) * 2008-02-29 2009-09-03 Egen, Inc. Modified poloxamers for gene expression and associated methods
AU2009292643B2 (en) 2008-09-19 2016-02-18 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US9399044B2 (en) 2014-05-28 2016-07-26 International Business Machines Corporation Antimicrobial cationic polyamines
WO2024153784A1 (en) * 2023-01-20 2024-07-25 Basf Se Use of butronics as small molecule solubilizers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227740A (en) * 1963-02-25 1966-01-04 Union Oil Co Preparation of alkyl carbonates
US4189609A (en) * 1974-08-19 1980-02-19 Basf Wyandotte Corporation Multi-block coupled polyoxyalkylene copolymer surfactants
DE2536121A1 (de) * 1974-08-19 1976-03-04 Basf Wyandotte Corp Oberflaechenaktive block-polyoxyalkylencopolymere
DE3786309T2 (de) * 1986-09-05 1994-02-10 American Cyanamid Co Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme.
US4866143A (en) * 1988-04-21 1989-09-12 Basf Corporation Novel surfactants based on poly(alkylene carbonate)s
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5650234A (en) * 1994-09-09 1997-07-22 Surface Engineering Technologies, Division Of Innerdyne, Inc. Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
WO1997005185A2 (en) * 1995-07-28 1997-02-13 Focal, Inc. Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
US5861174A (en) * 1996-07-12 1999-01-19 University Technology Corporation Temperature sensitive gel for sustained delivery of protein drugs
ZA978537B (en) * 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US6258351B1 (en) * 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
US7074878B1 (en) * 1999-12-10 2006-07-11 Harris J Milton Hydrolytically degradable polymers and hydrogels made therefrom
US6348558B1 (en) * 1999-12-10 2002-02-19 Shearwater Corporation Hydrolytically degradable polymers and hydrogels made therefrom
ATE391742T1 (de) * 2002-02-15 2008-04-15 Nektar Therapeutics Al Corp Hydrolytisch abbaubare polyalkylenoxid-polymere
JP4723244B2 (ja) * 2002-07-19 2011-07-13 オメロス コーポレイション 生分解性トリブロックコポリマー、その合成方法、ならびにそれから作製されるヒドロゲルおよび生体材料

Also Published As

Publication number Publication date
AU2003213152A1 (en) 2003-09-09
DE60320224T2 (de) 2009-05-14
WO2003070805A1 (en) 2003-08-28
US9040060B2 (en) 2015-05-26
ES2304501T3 (es) 2008-10-16
DE60320224D1 (de) 2008-05-21
EP1476489A1 (de) 2004-11-17
US20060239961A1 (en) 2006-10-26
EP1476489B1 (de) 2008-04-09
EP1476489B8 (de) 2008-10-08
US20110217343A1 (en) 2011-09-08

Similar Documents

Publication Publication Date Title
ATE391742T1 (de) Hydrolytisch abbaubare polyalkylenoxid-polymere
TW200500078A (en) Modified asialo-interferons and uses thereof
WO2005051316A3 (en) Polymer compositions and methods for their use
WO2001000246A3 (en) Hydrogels derived from chitosan and poly(ethylene glycol)
ATE327262T1 (de) Zusammensetzungen zur erhöhung des gewebevolumens und beschichtungszusammensetzungen
WO2004075923A3 (en) Polymer-factor viii moiety conjugates
DE60028415D1 (de) Methode und zusammensetzungen für verbesserte abgabevorrichtungen
CA2381729A1 (en) Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof
BR0210335A (pt) Copolìmero de blocos, e, composição
WO2004009664A3 (en) Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
DE60033969D1 (de) Hydrolytisch abbaubare carbamatderivate von polyethylenglykol
DE60044459D1 (de) IN ORGANISCHEN LÖSEMITTELN LÖSLICHE BIOLOGISCH ABBAUBARE POLY (ALKYLENOXID)- POLY (p-DIOXANON) BLOCKCOPOLYMERE SOWIE DIESE ENTHALTENDE ZUSAMMENSETZUNG ZUR ARZNEISTOFFVERABREICHUNG
DK1638539T3 (da) Farmaceutiske sammensætninger omfattende pH-sensitive blokcopolymerer og et hydrofobisk medikament
DE60331367D1 (de) Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
CA2355657A1 (en) Biodegradable ph/thermosensitive hydrogels for sustained delivery of biologically active agents
BR0311978A (pt) Preparação, método para preparar a mesma, formulação farmacêutica, métodos para tratar de uma sìndrome responsiva ao fator vii, para prevenir hemorragias indesejáveis, para prevenir coagulação sanguìnea indesejável e para prevenir as reações mediadas pelo fator tecidual, e, uso de uma preparação
WO2006023388A3 (en) Biodegradable diblock copolymers having reverse thermal gelation
WO2008073909A3 (en) Use of peo-pbo block copolymers in ophthalmic compositions
ATE306251T1 (de) Verwendung eines biologisch abbaubaren polymers
ATE328028T1 (de) Pharmazeutische zusammensetzung enthaltend polyalkylenoxide mit verringerten mengen an ameisensäure und ameisensäurederivaten
EP2716284A3 (de) Polyethylenoxidbasierte Folien und daraus hergestellte Arzneimittelabgabesysteme
MXPA02011111A (es) Polimeros biocidas a base de sales de guanidina.
ATE407963T1 (de) Biologisch abbaubare amin-enthaltende polyorthoester und blockcopolymere daraus
ATE372355T1 (de) Dl-lactid-e-caprolacton copolymere
WO2010147875A3 (en) Biomedical devices, polymeric materials and contact lenses comprising the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties